Loading...

The current price of EXOZ is 14.25 USD — it has decreased -0.63 % in the last trading day.
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
Wall Street analysts forecast EXOZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXOZ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
eXoZymes Inc revenue for the last quarter amounts to -2.52M USD, increased 56.49 % YoY.
eXoZymes Inc. EPS for the last quarter amounts to -1870018.00 USD, increased 245.33 % YoY.
eXoZymes Inc (EXOZ) has 31 emplpoyees as of December 15 2025.
Today EXOZ has the market capitalization of 120.27M USD.